{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:03:30Z","timestamp":1758845010404,"version":"3.44.0"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.urology.2020.08.032","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T16:34:52Z","timestamp":1598978092000},"page":"222-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Crizotinib-associated Renal Cyst Formation in a Pediatric Patient With ALK+ Epithelioid Inflammatory Myofibroblastic Sarcoma"],"prefix":"10.1016","volume":"149","author":[{"given":"Alexei","family":"Kopelevich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Holzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"La","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hollie A.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilibeth","family":"Torno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi A.","family":"Stephany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2020.08.032_bib0001","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cam4.437","article-title":"Complex renal cysts associated with crizotinib treatment","volume":"4","author":"Schnell","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.urology.2020.08.032_bib0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40644-017-0109-5","article-title":"Crizotinib associated renal cysts [CARCs]: incidence and patterns of evolution","volume":"17","author":"Cameron","year":"2017","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.urology.2020.08.032_bib0003","first-page":"65","article-title":"Crizotinib in ALK(+) inflammatory myofibroblastic tumors-current experience and future perspectives","author":"Theilen","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.urology.2020.08.032_bib0004","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1634\/theoncologist.2014-0216","article-title":"Spontaneous regression of crizotinib-associated complex renal cysts during continuous crizotinib treatment","volume":"19","author":"Klempner","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.urology.2020.08.032_bib0005","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2169\/internalmedicine.8445-16","article-title":"Regression of crizotinib-associated complex cystic lesions after switching to alectinib","volume":"56","author":"Taima","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.urology.2020.08.032_bib0006","first-page":"89","article-title":"Alectinib induced regression of renal and hepatic cysts caused by crizotinib","volume":"13","author":"Di Marino","year":"2020","journal-title":"Int Med Case Rep J"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520310293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520310293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:17:49Z","timestamp":1758766669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429520310293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":6,"alternative-id":["S0090429520310293"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2020.08.032","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crizotinib-associated Renal Cyst Formation in a Pediatric Patient With ALK+ Epithelioid Inflammatory Myofibroblastic Sarcoma","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2020.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}